mifepristone mifepristone
Stories About

mifepristone

Demonstrators rally in support of abortion rights at the Supreme Court in Washington, D.C., on Saturday. Andrew Caballero-Reynolds/AFP via Getty Images hide caption

toggle caption
Andrew Caballero-Reynolds/AFP via Getty Images

Packages of Mifepfex, the brand-name version of mifepristone, seen at a family planning clinic in Rockville, Md. Anna Moneymaker/Getty Images hide caption

toggle caption
Anna Moneymaker/Getty Images

Here's what really happened during the abortion drug's approval 23 years ago

  • Download
  • <iframe src="https://www.npr.org/player/embed/1169859888/1170246305" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A patient prepares to take mifepristone during a visit to an abortion provider in Kansas City, Kan., in October. A federal judge's preliminary injunction invalidating the FDA's approval of the common abortion medication could have far-reaching effects if it's allowed to stand. Charlie Riedel/AP hide caption

toggle caption
Charlie Riedel/AP

The pharmaceutical industry urges courts to preserve access to abortion pill

  • Download
  • <iframe src="https://www.npr.org/player/embed/1169598596/1169625041" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

The Justice Department had asked the 5th U.S. Circuit Court of Appeals in New Orleans for an emergency stay of an abortion pill ruling by a federal judge in Texas while the court hears the case. Jonathan Bachman/AP hide caption

toggle caption
Jonathan Bachman/AP

U.S. appeals court preserves partial access to abortion pill, but with tighter rules

  • Download
  • <iframe src="https://www.npr.org/player/embed/1169217172/1169655332" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A patient prepares to take the first of two pills for a medication abortion during a visit to a clinic in Kansas City, Kan., on Wednesday, Oct. 12, 2022. Charlie Riedel/AP hide caption

toggle caption
Charlie Riedel/AP

A federal judge in Texas ruled that U.S. Food and Drug Administration improperly approved an abortion pill over 20 years ago, testing the agency's authority. Jacquelyn Martin/AP hide caption

toggle caption
Jacquelyn Martin/AP

How an abortion pill ruling could threaten the FDA's regulatory authority

  • Download
  • <iframe src="https://www.npr.org/player/embed/1169194827/1169194828" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Misoprostol is typically used as part of a two-drug protocol for a medication abortion. But it is also safe and effective when used alone, doctors say. ROBYN BECK/AFP via Getty Images hide caption

toggle caption
ROBYN BECK/AFP via Getty Images

Medication abortion is still possible with just one drug. Here's how it works

  • Download
  • <iframe src="https://www.npr.org/player/embed/1168857095/1169145619" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Mifepristone is part of a two-drug protocol that a recent study showed was used in 98% of medication abortions in 2020. Allen G. Breed/AP hide caption

toggle caption
Allen G. Breed/AP

Judges' dueling decisions put access to a key abortion drug in jeopardy nationwide

  • Download
  • <iframe src="https://www.npr.org/player/embed/1159220452/1168770851" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The J. Marvin Jones Federal Building and Mary Lou Robinson United States Courthouse in Amarillo, Texas, where U.S. District Judge Matthew Kacsmaryk will decide on a lawsuit over the abortion drug mifepristone. Justin Rex/AP hide caption

toggle caption
Justin Rex/AP

Walgreens announced last week that it'd stop selling mifepristone, a popular abortion pill, in red states. California Gov. Gavin Newsom says his state will cut ties with the pharmacy giant after the move. Michael M. Santiago/Getty Images hide caption

toggle caption
Michael M. Santiago/Getty Images

A Walgreens pharmacy is pictured on Jan. 5 in New York City. Walgreens says it won't sell mifepristone in states where Republican attorneys general threatened legal action. Michael M. Santiago/Getty Images hide caption

toggle caption
Michael M. Santiago/Getty Images

Mifepristone was approved by the Food and Drug Administration in 2000 to induce first-trimester abortions in combination with a second drug, misoprostol. Charlie Neibergall/AP hide caption

toggle caption
Charlie Neibergall/AP

Democratic state attorneys general sue Biden administration over abortion pill rules

  • Download
  • <iframe src="https://www.npr.org/player/embed/1159375337/1159528687" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Misoprostol is currently approved by the FDA for use as an ulcer drug, not as a standalone abortion pill. Doctors already use it off-label for a variety of gynecological purposes beyond abortion, including for IUD insertion and for labor and delivery. Victor R. Caivano/AP hide caption

toggle caption
Victor R. Caivano/AP

Why an ulcer drug could be the last option for many abortion patients

  • Download
  • <iframe src="https://www.npr.org/player/embed/1159075709/1159208092" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The Food and Drug Administration announced it has loosened some restrictions on the pill mifepristone, allowing it to be dispensed by more pharmacies and without an in-person exam. Charlie Neibergall/AP hide caption

toggle caption
Charlie Neibergall/AP

Containers of mifepristone and misoprostol — medications used to end a pregnancy — sit on a table inside of a Planned Parenthood clinic in Fairview Heights, Ill. Jeff Roberson/AP hide caption

toggle caption
Jeff Roberson/AP

Activists participate in a candlelight vigil for abortion rights near the U.S. Supreme Court on Dec. 13. Alex Wong/Getty Images hide caption

toggle caption
Alex Wong/Getty Images

FDA relaxes controversial restrictions on access to abortion pill by mail

  • Download
  • <iframe src="https://www.npr.org/player/embed/1064598531/1064614679" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript